PROshot: Internal Mammary Coverage, Dose-Reduced Radiation After Transoral Surgery, Sequencing of Total Neoadjuvant Therapy for Rectal Cancer, Hypofractionated Whole Breast Intensity Modulated Radiation Therapy, Hypofractionated Prostate Fossa Radiation Therapy, and Stereotactic Body Radiation Therapy for Oligoprogressive Cancer.
作者信息
Dulaney Caleb, Dover Laura
机构信息
Department of Radiation Oncology, Anderson Regional Health System, Meridian, Mississippi.
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
出版信息
Pract Radiat Oncol. 2022 Mar-Apr;12(2):79-83. doi: 10.1016/j.prro.2021.12.010.
PMID:35248240
Abstract
摘要
相似文献
1
PROshot: Internal Mammary Coverage, Dose-Reduced Radiation After Transoral Surgery, Sequencing of Total Neoadjuvant Therapy for Rectal Cancer, Hypofractionated Whole Breast Intensity Modulated Radiation Therapy, Hypofractionated Prostate Fossa Radiation Therapy, and Stereotactic Body Radiation Therapy for Oligoprogressive Cancer.PROshot：内乳覆盖、经口手术后剂量降低的放疗、直肠癌全新辅助治疗的序贯治疗、大分割全乳调强放疗、大分割前列腺窝放疗以及寡进展性癌的立体定向体部放疗
Pract Radiat Oncol. 2022 Mar-Apr;12(2):79-83. doi: 10.1016/j.prro.2021.12.010.
2
Extreme Hypofractionation with SBRT in Localized Prostate Cancer.局限性前列腺癌的 SBRT 超分割放疗。
Curr Oncol. 2021 Aug 3;28(4):2933-2949. doi: 10.3390/curroncol28040257.
3
Energy use in moderate hypofractionation and stereotactic body radiotherapy for prostate cancer.
BJU Int. 2023 Dec;132(6):648-650. doi: 10.1111/bju.16151. Epub 2023 Aug 21.
4
Stereotactic body radiation therapy for prostate cancer-a review.前列腺癌的立体定向体部放射治疗——综述
Chin Clin Oncol. 2017 Sep;6(Suppl 2):S10. doi: 10.21037/cco.2017.06.05.
5
Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost.加速Hypofractionated 全骨盆放射治疗在高剂量率近距离治疗或立体定向体部放射治疗前列腺加量之前的安全性。
Radiat Oncol. 2022 Jan 20;17(1):12. doi: 10.1186/s13014-021-01976-2.
6
[Hypofractionated radiotherapy in prostate cancer].[前列腺癌的大分割放疗]
Cancer Radiother. 2013 Oct;17(5-6):349-54. doi: 10.1016/j.canrad.2013.05.005. Epub 2013 Aug 20.
7
A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.中高危前列腺癌调强放疗与立体定向体部放疗(SBRT)推量的初步研究。
Technol Cancer Res Treat. 2010 Oct;9(5):453-62. doi: 10.1177/153303461000900503.
8
Current status of intensity-modulated radiation therapy for prostate cancer: History, clinical results and future directions.前列腺癌调强放疗的现状：历史、临床结果和未来方向。
Int J Urol. 2019 Aug;26(8):775-784. doi: 10.1111/iju.14011. Epub 2019 May 21.
9
Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers.在前列腺癌极超分割放疗中，针对优势前列腺内病灶同步整合增敏（SIB）：直肠间隔物的影响。
Radiat Oncol. 2022 Feb 22;17(1):38. doi: 10.1186/s13014-022-02003-8.
10
Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial.前列腺癌大分割调强放射治疗后患者报告的泌尿、肠道和性功能：一项随机试验的结果
Am J Clin Oncol. 2018 Jun;41(6):558-567. doi: 10.1097/COC.0000000000000325.
Zotero 插件